Investment in patents always leads market activity. So Apex Neuro's investments in key research and development implicate its positioning for market launch in the coming years.
So far, Patent Forecast shows 5 patent assets from Apex Neuro since 2019. All 5 relate to AI-driven electrophysiological neuromodulation of the brain. Most people have never heard of Apex Neuro because the company is not yet selling products, advertising, or even operating a fully functional website. That being said, that patent data does not lie. Apex Neuro is actively seeking patent protection in the Neuromodulation field, and competitors such as Boston Scientific, Philips, Psomagen Inc., Halo Neuro, and Neurosteer should take note.
To stay on top of the most recent patent data and be the first to know when a competitor enters your field, make sure to check out the various interactive AI Biotech/Diagnostics sectors available through the Patent Forecast®.
